 |
| Pelatihan Budidaya dan Pengolahan Daun Afrika |
Mendaftarlah dari sekarang untuk mulai menanam bibit stek pohon daun afrika
Daun Afrika Inovasi Nusantara DAIN usaha tani, pendidikan dan latihan (seminar, training, workshop), jual bibit stek daun afrika dengan harga Rp150.000 (12 batang) termasuk ongkos kirim pulau Jawa. Hubungi hotline DAIN Daun Afrika Inovasi Nusantara 081398251010 BB 5895a5bb Kebun percontohan Griya Bandung Indah B5-3 Tel 022-7533777 Bandung
Jumat, 14 Maret 2014
Kamis, 06 Maret 2014
Training Herbal 2014
Pertama dan Satu-satunya di Indonesia
Training 101 Daun Afrika (TEMPAT TERBATAS)
Fasilitas:
1. Bibit 12 stek pohon Daun Afrika dikirim Maret 2014+daun
sampel
2. Modul Referensi (Hasil penelitian ilmiah dan uji klinis
dari seluruh dunia)
3. Modul Pengetahuan Pengobatan Herbal
4. Modul Produksi Kapsul Herbal Daun Afrika
5. Modul Produksi Minuman Fermentasi "Frink"
6. Modul Produksi "Xigar"
7. Pemeriksaan darah secara Hemaview (3 x pengambilan
sampel) + konsultasi
Waktu training: September atau Desember 2014 (pilih 1)
Tempat: hotel di Bandung (diberitahukan kemudian)
Biaya: Rp980.000,- (sebelum April 2014)
Biaya: Rp1.500.000 (setelah April 2014)
Ditransfer melalui Rekening Bank BCA
Nomor: 7770893377 a.n. Dainsyah
Konfirmasi: 081398251010
Kebun contoh: GBI B5-3 Ciwastra Bandung Tel. 022-7533777
Salam sehat,
Dainsyah, S.Si.
Sarjana Biologi ITB
Herbalist lulusan Karyasari
Analis Laboratorium Hemaview (LBA/DBA)
Setelah registrasi, peserta langsung mendapatkan stek bibit
dan melakukan pemeriksaan darah awal.
Sabtu, 22 Februari 2014
Daun afrika, lalapan pahit penjinak penyakit
Daun afrika atau daun afrika selatan, diterjemahkan dari
penamaan tiongkok Nan Fei Shu atau dalam logat lain Nan Hui Ye (Nan artinya
selatan, kan?) Tumbuhan ini bukan merupakan khasanah tanaman obat asli
Tiongkok. Lalu mengapa ahli-ahli RRC menggebu-gebu meneliti dan
men-sosialisasikan tanaman yang lazim tumbuh di benua Afrika bagian tropis ini?
Apakah Anda penderita diabetes? Tekanan darah tinggi? Kadar kolesterol darah melonjak? Persendian sakit akibat kadar asam urat melangit? Tenang, sebentar lagi halaman rumah Anda dapat dengan mudah menyediakan obatnya. Dan khasiatnya bukan sugesti, tapi secara ilmiah terbukti.
Pembuktian daun afrika sebagai obat aneka penyakit bukan sekadar isapan jempol. Bukti khasiatnya tidak sebatas testimoni konsumen. Manfaat kesehatan daun afrika terbukti dalam beragam riset ilmiah bahkan pada level uji klinis. Bejibun jurnal ilmiah internasional menulis laporan kajian biomedik tumbuhan asal afrika bagian trpika ini. Peneliti dari negara maju semacam USA, Jerman, Australia tidak mau tertinggal pula. Bahkan gudangnya danmbah-nya pengobatan herbal, yaitu Cina, cukup intensif meneliti tanaman asing ini. Mungkin hanya peneliti Indonesia yang belum menaruh minat terhadap keajaiban tanaman yang tumbuh ideal di ketinggian di atas 1500 meter dpl.
Tetangga sebelah rumah yang juga masuk kelompok lansia melaporkan sakit lututnya sembuh. Ibu yang sulit bangkit dari duduk shalatnya, kini tidak lagi merasakan nyeri yang menyiksa. Besannya, yang dia anjurkan juga, sempat datang dan meminta bibit stek, juga melaporkan hal yang sama. Yang lain, seorang Ibu usia 40 tahunan melaporkan kini dia sehari-hari merasakan lebih "fresh." Beberapa pria anggota klub jalan pagi di Tangerang mengaku tekanan darah tinggi yang membandel kini sirna, hal yang tidak pernah berhasil selama memakai obat dokter dan mengonsumsi herbal mahal.
Daun afrika telah diteliti, spektrum bidang dan topiknya sangat lebar. Sejak 2004, jumlah topik penelitian di Australia meningkat pesat. Penelitian bilateral antara USA dan Cina juga ada. Topik penelitian antara lain tentang diabetes, kanker, tekanan darah, sindrom dismetabolik, malaria, parasitologi, ekologi dan lingkungan. Selain dalam bidang biomedik, peternakan dan kedokteran hewan juga menggebu berpacu mengungkap bukti-bukti kemandragunaan daun afrika.
Salam akademia.-
Selasa, 21 April 2009
TIDAK ADA KOLESTEROL JAHAT, RADIKAL BEBAS YG JAHAT
Cholesterol Essential for Good Health
Two new studies show that cholesterol protects against neurological dysfunction and reduces risk of cancer. Cholesterol has long been recognized as an essential element in our bodies. Every cell in your body contains cholesterol where it functions as an important structural building block and helps protect against destructive free radicals. It is required in order to make vitamin D and hormones such as testosterone, estrogen, and progesterone. Nerve cells have higher amounts of cholesterol than other cells because nerve cells do not split and divide like other cells and so they need the extra cholesterol to live longer. Yes, cholesterol helps our nerve tissues live longer.
Scientists have found that cholesterol is not just a structural element in nerve tissue, but is needed for healthy nerve and brain function. A recent study1 has demonstrated that cholesterol is absolutely vital for proper nerve transmission.
This new discovery adds more troubling implications to the widespread use of cholesterol-lowering statin drugs. Statins interfere with liver function and block its ability to make cholesterol. Less cholesterol in the blood means less is available for making and maintaining the health of cell membranes, reduces the body’s ability to form vitamin D and essential hormones. It also interferes with the body’s ability to maintain healthy nerve and brain tissues. This may explain why rates of depression, memory loss, and suicide are higher among statin users.
The new study adds a brand new explanation for nerve and muscle related problems from taking statins. Researchers studied the structure of an important neurotransmitter receptor called the nicotinic acetylcholine receptor. Cholesterol is absolutely vital to this receptor working correctly and is part of the protein structure of this receptor. Problems with this receptor’s function, drastically alters nerve transmission. This new discovery offers a new explanation as to why statins have so many devastating nerve and muscle side effects.
Research has shown that people taking cholesterol lowering drugs die more frequently from a variety of causes than those that don’t take the drugs. While statin drugs have many side effects, some of the detrimental effects of using these drugs also come as a result of lowering the cholesterol. Even those who don’t take statin drugs who have low blood cholesterol are at risk.
Another recent study2 has shown that low cholesterol levels increase the risk of developing cancer. Even low amounts LDL cholesterol, the so-called bad cholesterol which is believed to be the most problematic, increases risk. The American Heart Association (AHA) recommends that LDL level of 100 ml/dL or less for prevention and no more than 70 for high risk patients. In the new study an LDL level of 107, which is above the AHA safety level, was associated with a 33 percent increased risk of cancer and death, an LDL level of 87 was associated with a 50 percent increased risk. As the LDL goes lower the risk keeps getting worse. The LDL levels set by the AHA were chosen arbitrary by "experts" with direct financial ties to the statin industry. They knew full well that reaching their artificially low target levels for LDL would require larger doses of statin drugs thus dramatically increasing sales (which has indeed happened).
The results of this new study was so alarming that the study authors challenged other researchers to examine their data for any possible errors and called for a statistical reanalysis of the data from all other existing cholesterol studies, using better statistical models that actually reflect true risk. The results of this new research led the authors to conclude "A low LDL cholesterol level is not necessarily associated with optimal clinical outcomes but is a predictor of cancer and death."
In the current study the ideal LDL cholesterol level was found to be 126. The researchers were able to identify a bell shaped curve, in terms of a departure in either direction from this ideal number. LDL over 146 or less than 107 was associated with 33 percent increased risk of cancer. LDL over 164 or less than 87 was associated with a 50 percent increased risk. The risk keeps getting worse the higher or lower the number progresses away from the ideal of 126. LDL in the range of 108 – 145 had no statistically significant cancer risk, although being in the center of this range is clearly best.
There have been a number of studies in the past that link low cholesterol and cancer risk. However, these studies could not prove that the cancer was not already there prior to the start of the study – which has been the main argument used (besides statistical manipulation) by the statin industry to deny the association. In the new study this issue was taken into account by eliminating participants with less than 2.5 years follow-up after the start of the study, thus demonstrating that the results were not due to preexisting cancer. ■
References
1. Biophysicists Create New Model For Protein-cholesterol Interactions In Brain And Muscle Tissue. Proceedings of the National Academy of Sciences. October, 2008.
2. Xilin Yang PhD, WingYee So MBChB, Gary T.C. Ko MD, Ronald C.W. Ma MBChB, Alice P.S. Kong MBChB, Chun-Chung Chow MBBS, Peter C.Y. Tong PhD, Juliana C.N. Chan MD Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. Canadian Medical Association Journal 2008;179(5):427-37.
Cholesterol Does Not Cause Heart Disease Study Says
The lipid hypothesis of heart disease which suggested that high blood cholesterol was the underlying cause of heart attacks and strokes was proposed over 45 years ago. In that time thousands of studies have been published trying to prove this theory correct. Yet, not one has been able to show a cause and effect relationship. Why the failure? Because cholesterol does not cause heart disease. What has been proven by all this research is that high blood cholesterol does not cause heart disease.
So why is there such a push for taking statins—the cholesterol-lowering drugs? The answer is simple—profit. Statins, are among the biggest profit makers for drug companies, bringing in billions of dollars a year. Last year drug companies raked in over $20 billion from cholesterol-lowering drugs. These companies are not about to cut off this lucrative cash flow. For this reason, they very aggressively promote the belief that high blood cholesterol causes heart disease and the only way to fight it is by lowering cholesterol with drugs.
Money and power buys friends. The pharmaceutical industry has many friends in the medical community. The American Heart Association recently stated that if you want to avoid a heart attack, to stop taking vitamins and switch to cholesterol-lowering statin drugs instead. (Matthew Herper and Robert Langreth, Eat your Statins, Forbes Nov. 16. 2008.)
Because of pressure from the pharmaceutical industry and the fear of losing advertising dollars, medical journals have been reluctant to publish articles opposing the interests of the drug companies. In recent years, however, many books and even medical journals have come out exposing the cholesterol myth. The most recent was published in the Scandinavian Cardiovascular Journal and authored by Dr. Paul Rosch of New York Medical College.
In his article he states, “The belief that coronary atherosclerosis is due to high cholesterol from increased saturated fat intake originated from experiments in herbivorous animals. It was reinforced by reports allegedly demonstrating this sequence of events in various populations but ignoring contradictory data. The idea has been perpetuated by powerful forces using similar tactics to preserve the profit and the reputations of those who promote this doctrine. Opponents find it difficult to publish their scientifically supported opinions. The advent of statins has further fuelled this fallacious lipid hypothesis, despite compelling evidence that their effect is not due to cholesterol lowering and that serious side effects have been suppressed and alleged benefits have been hyped. The adverse effects of the cholesterol campaign on health, quality of life, the economy and medical research are inestimable. It is imperative that public health officials, physicians and patients are apprised of proof that it is misguided, malicious and malignant.”1
High blood cholesterol may actually be good and may even protect against diseases such as infections and, believe it or not, heart disease. So says Uffe Ravnskov, MD, PhD.2 Dr. Ravnskov documents his favorable stand on cholesterol in an article published in the QJM: An International Journal of Medicine published by Oxford University. To read the article go here. ■
1. Rosch P.J. Cholesterol does not cause coronary heart disease in contrast to stress. Scand Cardiovasc J 2008; 42:244-249.
2. Ravnskov, U. High cholesterol may protect against infections and atherosclerosis. Q J Med 2003;96:927-934.
Two new studies show that cholesterol protects against neurological dysfunction and reduces risk of cancer. Cholesterol has long been recognized as an essential element in our bodies. Every cell in your body contains cholesterol where it functions as an important structural building block and helps protect against destructive free radicals. It is required in order to make vitamin D and hormones such as testosterone, estrogen, and progesterone. Nerve cells have higher amounts of cholesterol than other cells because nerve cells do not split and divide like other cells and so they need the extra cholesterol to live longer. Yes, cholesterol helps our nerve tissues live longer.
Scientists have found that cholesterol is not just a structural element in nerve tissue, but is needed for healthy nerve and brain function. A recent study1 has demonstrated that cholesterol is absolutely vital for proper nerve transmission.
This new discovery adds more troubling implications to the widespread use of cholesterol-lowering statin drugs. Statins interfere with liver function and block its ability to make cholesterol. Less cholesterol in the blood means less is available for making and maintaining the health of cell membranes, reduces the body’s ability to form vitamin D and essential hormones. It also interferes with the body’s ability to maintain healthy nerve and brain tissues. This may explain why rates of depression, memory loss, and suicide are higher among statin users.
The new study adds a brand new explanation for nerve and muscle related problems from taking statins. Researchers studied the structure of an important neurotransmitter receptor called the nicotinic acetylcholine receptor. Cholesterol is absolutely vital to this receptor working correctly and is part of the protein structure of this receptor. Problems with this receptor’s function, drastically alters nerve transmission. This new discovery offers a new explanation as to why statins have so many devastating nerve and muscle side effects.
Research has shown that people taking cholesterol lowering drugs die more frequently from a variety of causes than those that don’t take the drugs. While statin drugs have many side effects, some of the detrimental effects of using these drugs also come as a result of lowering the cholesterol. Even those who don’t take statin drugs who have low blood cholesterol are at risk.
Another recent study2 has shown that low cholesterol levels increase the risk of developing cancer. Even low amounts LDL cholesterol, the so-called bad cholesterol which is believed to be the most problematic, increases risk. The American Heart Association (AHA) recommends that LDL level of 100 ml/dL or less for prevention and no more than 70 for high risk patients. In the new study an LDL level of 107, which is above the AHA safety level, was associated with a 33 percent increased risk of cancer and death, an LDL level of 87 was associated with a 50 percent increased risk. As the LDL goes lower the risk keeps getting worse. The LDL levels set by the AHA were chosen arbitrary by "experts" with direct financial ties to the statin industry. They knew full well that reaching their artificially low target levels for LDL would require larger doses of statin drugs thus dramatically increasing sales (which has indeed happened).
The results of this new study was so alarming that the study authors challenged other researchers to examine their data for any possible errors and called for a statistical reanalysis of the data from all other existing cholesterol studies, using better statistical models that actually reflect true risk. The results of this new research led the authors to conclude "A low LDL cholesterol level is not necessarily associated with optimal clinical outcomes but is a predictor of cancer and death."
In the current study the ideal LDL cholesterol level was found to be 126. The researchers were able to identify a bell shaped curve, in terms of a departure in either direction from this ideal number. LDL over 146 or less than 107 was associated with 33 percent increased risk of cancer. LDL over 164 or less than 87 was associated with a 50 percent increased risk. The risk keeps getting worse the higher or lower the number progresses away from the ideal of 126. LDL in the range of 108 – 145 had no statistically significant cancer risk, although being in the center of this range is clearly best.
There have been a number of studies in the past that link low cholesterol and cancer risk. However, these studies could not prove that the cancer was not already there prior to the start of the study – which has been the main argument used (besides statistical manipulation) by the statin industry to deny the association. In the new study this issue was taken into account by eliminating participants with less than 2.5 years follow-up after the start of the study, thus demonstrating that the results were not due to preexisting cancer. ■
References
1. Biophysicists Create New Model For Protein-cholesterol Interactions In Brain And Muscle Tissue. Proceedings of the National Academy of Sciences. October, 2008.
2. Xilin Yang PhD, WingYee So MBChB, Gary T.C. Ko MD, Ronald C.W. Ma MBChB, Alice P.S. Kong MBChB, Chun-Chung Chow MBBS, Peter C.Y. Tong PhD, Juliana C.N. Chan MD Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. Canadian Medical Association Journal 2008;179(5):427-37.
Cholesterol Does Not Cause Heart Disease Study Says
The lipid hypothesis of heart disease which suggested that high blood cholesterol was the underlying cause of heart attacks and strokes was proposed over 45 years ago. In that time thousands of studies have been published trying to prove this theory correct. Yet, not one has been able to show a cause and effect relationship. Why the failure? Because cholesterol does not cause heart disease. What has been proven by all this research is that high blood cholesterol does not cause heart disease.
So why is there such a push for taking statins—the cholesterol-lowering drugs? The answer is simple—profit. Statins, are among the biggest profit makers for drug companies, bringing in billions of dollars a year. Last year drug companies raked in over $20 billion from cholesterol-lowering drugs. These companies are not about to cut off this lucrative cash flow. For this reason, they very aggressively promote the belief that high blood cholesterol causes heart disease and the only way to fight it is by lowering cholesterol with drugs.
Money and power buys friends. The pharmaceutical industry has many friends in the medical community. The American Heart Association recently stated that if you want to avoid a heart attack, to stop taking vitamins and switch to cholesterol-lowering statin drugs instead. (Matthew Herper and Robert Langreth, Eat your Statins, Forbes Nov. 16. 2008.)
Because of pressure from the pharmaceutical industry and the fear of losing advertising dollars, medical journals have been reluctant to publish articles opposing the interests of the drug companies. In recent years, however, many books and even medical journals have come out exposing the cholesterol myth. The most recent was published in the Scandinavian Cardiovascular Journal and authored by Dr. Paul Rosch of New York Medical College.
In his article he states, “The belief that coronary atherosclerosis is due to high cholesterol from increased saturated fat intake originated from experiments in herbivorous animals. It was reinforced by reports allegedly demonstrating this sequence of events in various populations but ignoring contradictory data. The idea has been perpetuated by powerful forces using similar tactics to preserve the profit and the reputations of those who promote this doctrine. Opponents find it difficult to publish their scientifically supported opinions. The advent of statins has further fuelled this fallacious lipid hypothesis, despite compelling evidence that their effect is not due to cholesterol lowering and that serious side effects have been suppressed and alleged benefits have been hyped. The adverse effects of the cholesterol campaign on health, quality of life, the economy and medical research are inestimable. It is imperative that public health officials, physicians and patients are apprised of proof that it is misguided, malicious and malignant.”1
High blood cholesterol may actually be good and may even protect against diseases such as infections and, believe it or not, heart disease. So says Uffe Ravnskov, MD, PhD.2 Dr. Ravnskov documents his favorable stand on cholesterol in an article published in the QJM: An International Journal of Medicine published by Oxford University. To read the article go here. ■
1. Rosch P.J. Cholesterol does not cause coronary heart disease in contrast to stress. Scand Cardiovasc J 2008; 42:244-249.
2. Ravnskov, U. High cholesterol may protect against infections and atherosclerosis. Q J Med 2003;96:927-934.
Minggu, 05 April 2009
SEHAT LEBIH JELAS, JELAS LEBIH SEHAT
Mencegah lebih baik daripada mengobati.
Demi mengetahui status kesehatan, sebelum sakit menjadi nyata, para dokter naturapati di USA dan Australia menggunakan metode:
- Hemaview/Live Blood Analysis, dan
- Free-Radical Screening.
- kelengketan darah dan adanya plak kolesterol penyebab PJK dan stroke
- gangguan pencernaan
- serapan kalsium
- radikal bebas penyebab tumor/kanker
- dismetabolic syndrome (asam urat/diabetes)
- stres ginjal
- stres organ reproduksi (myom, kista, prostat)
Perkumpulan Biomedical Holistic Center
Visi: Menjadi pusat unggulan untuk pengembangan terapi biomedik-holistik di Indonesia.
Misi:
1. Menyediakan layanan pemeriksaan darah holistik yang secara internasional dikenal dengan istilah Hemaview.
2. Melaksanakan kegiatan edukasi, komunikasi, dan informasi (KIE) dalam bidang kesehatan holistik.
3. Memberikan penyuluhan/konsultasi kesehatan holistik kepada masyarakat luas.
4. Membina hubungan dengan para pakar, industriawan, komunitas, dan praktisi yang berkecimpungan dalam bidang biomedik-holistik.
Dalam menjalankan misinya Perkumpulan Biomedical Holistik Center mengusung "brand" HEMONITOR.
HEMONITOR adalah amal usaha yang berbasis pada konsep "Self and Spontaneous Healing."
HEMONITOR dilengkapi peralatan lab yg menggabungkan metode hemaview (live blood analysis/LBA) dan free-radical screening.
HEMONITOR berdiri sejak 2007; bekerja sama dg banyak kalangan, termasuk dokter, memeriksa prospek kesehatan melalui 2 tetes darah agar "Sehat Lebih Jelas, Jelas Lebih Sehat."
HEMONITOR menyediakan layanan terapi laser darah, yang aman, ampuh, dan murah, untuk mengaktifkan kembali sel-sel darah, menghilangkan perlengketan sel-sel darah merah (roulouex) yang membebani kerja jantung, dan melumerkan plak kolesterol/black thromboses penyebab stroke dan Penyakit Jantung Koroner (PJK).
HEMONITOR menyediakan pilihan produk herbal yg direkomendasikan berdasarkan status hasil pemeriksaan darah, dan memantau perkembangan manfaat dari mengonsumsinya, setiap bulan. Untuk konsumen dg status member, pemeriksaan rutin GRATIS.
HEMONITOR bekerja sama dengan bbrp suplayer makanan kesehatan, baik yg memasarkan dg sistem konvensional, MLM, dan UKM.
HEMONITOR per 9 April 2009, menetapkan biaya2 sebagai berikut:
1. Pemeriksaan darah dan konsultasi gaya hidup sehat holistik non member sebesar Rp30.000, minimal peserta 10 orang.
2. Terapi laser darah Rp100.00 dan diskon 50% jika telah memiliki nosel (terapi ulangan).
3. Untuk luar kota selain Jakarta, dikenai tambahan biaya transportasi dan akomodasi.
Silakan menghubungi kami: Dainsyah (081398251010 BB: 5895a5bb) atau Tita Sutriasi (081313350806)
Misi:
1. Menyediakan layanan pemeriksaan darah holistik yang secara internasional dikenal dengan istilah Hemaview.
2. Melaksanakan kegiatan edukasi, komunikasi, dan informasi (KIE) dalam bidang kesehatan holistik.
3. Memberikan penyuluhan/konsultasi kesehatan holistik kepada masyarakat luas.
4. Membina hubungan dengan para pakar, industriawan, komunitas, dan praktisi yang berkecimpungan dalam bidang biomedik-holistik.
Dalam menjalankan misinya Perkumpulan Biomedical Holistik Center mengusung "brand" HEMONITOR.
HEMONITOR adalah amal usaha yang berbasis pada konsep "Self and Spontaneous Healing."
HEMONITOR dilengkapi peralatan lab yg menggabungkan metode hemaview (live blood analysis/LBA) dan free-radical screening.
HEMONITOR berdiri sejak 2007; bekerja sama dg banyak kalangan, termasuk dokter, memeriksa prospek kesehatan melalui 2 tetes darah agar "Sehat Lebih Jelas, Jelas Lebih Sehat."
HEMONITOR menyediakan layanan terapi laser darah, yang aman, ampuh, dan murah, untuk mengaktifkan kembali sel-sel darah, menghilangkan perlengketan sel-sel darah merah (roulouex) yang membebani kerja jantung, dan melumerkan plak kolesterol/black thromboses penyebab stroke dan Penyakit Jantung Koroner (PJK).
HEMONITOR menyediakan pilihan produk herbal yg direkomendasikan berdasarkan status hasil pemeriksaan darah, dan memantau perkembangan manfaat dari mengonsumsinya, setiap bulan. Untuk konsumen dg status member, pemeriksaan rutin GRATIS.
HEMONITOR bekerja sama dengan bbrp suplayer makanan kesehatan, baik yg memasarkan dg sistem konvensional, MLM, dan UKM.
HEMONITOR per 9 April 2009, menetapkan biaya2 sebagai berikut:
1. Pemeriksaan darah dan konsultasi gaya hidup sehat holistik non member sebesar Rp30.000, minimal peserta 10 orang.
2. Terapi laser darah Rp100.00 dan diskon 50% jika telah memiliki nosel (terapi ulangan).
3. Untuk luar kota selain Jakarta, dikenai tambahan biaya transportasi dan akomodasi.
Silakan menghubungi kami: Dainsyah (081398251010 BB: 5895a5bb) atau Tita Sutriasi (081313350806)
Langganan:
Postingan (Atom)